Fundraising Fox
Cullinan Oncology
Founded 2016 · 128 employees on LinkedIn · 5 known investors
Find your way into Cullinan Oncology
Sign up to see every warm intro you have to Cullinan Oncology
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cullinan Oncology team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cullinan Therapeutics develops clinical-stage T cell engager therapies targeting autoimmune diseases and cancer, leveraging immune modulation expertise to advance high-impact therapeutic candidates.
Investors · 5
Lilly Asia Ventureslisted by Lilly Asia VenturesHong Kongvia Hongbo Lu · inferred
How we know: the VCSheet dataset · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BJun 2020Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Related companies · 2
Cullinan TherapeuticsCullinan Therapeutics is a clinical-stage biotech company developing therapeutic molecules for autoimmune diseases and cancer, with expertise in immune modulation. The company focuses on first- or best-in-class treatments to improve outcomes for patients managing these conditions.
Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Companies working in the same space as Cullinan Oncology.
Frequently asked questions
- What does Cullinan Oncology do?
- Cullinan Therapeutics develops clinical-stage T cell engager therapies targeting autoimmune diseases and cancer, leveraging immune modulation expertise to advance high-impact therapeutic candidates.
- Who are Cullinan Oncology's investors?
- Cullinan Oncology's investors include LAV, Lilly Asia Ventures, MPM BioImpact, Schooner Capital, Taiho Ventures, LLC.